# MedaSystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medasystems

- Industry: Software
- Headquarters: Menlo Park, US
- Website: www.medasystems.com
- Latest round: Seed (Mar 5, 2025)
- Investors on record: 2

## About

Founded in 2020 by Matthew Rosen, Jeffrey Thibeault, and John Langlands, and based in California, US, MedaSystems, Inc. operates as a digital health software company. The CEO of the company is Fiona Smythe. In March 2025, MedaSystems, Inc. raised an undisclosed amount of seed funding from returning investors Debiopharm Innovation Fund and Nina Capital. An individual investor also participated in the round. MedaSystems, Inc. develops a platform Expanded Access, which allows patients with conditions such as cancer, ALS, and Alzheimer's disease and who are not eligible to participate in clinical trials, to request access to investigational therapies that have not yet gained authorization from local regulatory authorities. The company develops a platform where pharmaceutical manufacturers and healthcare providers can collaborate on Expanded Access requests. The company will utilize the March 2025 funding to increase its development and activities.

## Funding rounds

- Seed, Mar 5, 2025 — Debiopharm Innovation Fund, Nina Capital
- Seed, Oct 12, 2023 — Nina Capital

## Investors

- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed
- Debiopharm Innovation Fund (https://capitalatlas.ai/funds/debiopharm-innovation-fund) — Seed